Trump Media Says Truth API Draws 10+ Customers as Conflict Concerns Grow 
UNAIDS Urges U.S. to Reconsider South Africa HIV Funding Withdrawal 
UK Retail Sales Rise as World Cup and Heatwave Boost Food, Pubs and Clothing 
Neuralink Expands Brain Implant Trials with 12 Global Patients 
AstraZeneca Shares Sink After Wainua Trial Misses Key Heart Disease Goal 
US Dollar Near Two-Month Low as Markets Await Inflation Data 
Oil Prices Rise as US-Iran Talks Stall, Inflation Risks Grow 
The government is ‘doubling down’ on its social media ban. But bigger penalties for platforms aren’t enough 
Nvidia to Invest Up to $3 Billion in Blackstone-Backed Lancium 
NASA Artemis II: First Crewed Moon Mission Since Apollo Takes Four Astronauts on 10-Day Lunar Journey 
Trump Administration Bars U.S. Travelers From Congo Flights Amid Ebola Outbreak 
JPMorgan Plans More Asia-Pacific Hiring in 2027 as Corporate Banking Revenue Surges 
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 
Wall Street Slips as Oil Prices Surge 5% on Iran-Hormuz Uncertainty 
Singapore Raises 2026 GDP Growth Forecast to 4.5%-5.5% as AI Boom Fuels Economy 
Novo Nordisk Eyes Turnaround as Oral Wegovy Challenges Eli Lilly in Weight-Loss Drug Race 
A South Korean research team has developed a strip-type urine test that successfully diagnoses prostate and pancreatic cancer on-site by amplifying the optical signal of the metabolome in urine.
The joint research team is from the Korea Institute of Materials Science, Pohang University of Science and Technology, and Kyung Hee University
The surface-enhanced Raman scattering sensor that they developed can amplify the optical signal of the metabolome in urine by more than 1 billion times by forming a coral reef-shaped plasmonic nanomaterial on top of porous paper material.
A light irradiation after a 10-microliter urine droplet amplified signal of cancer metabolome on the sensor’s surface without the need to go through a separate analysis process,.
The application of an artificial intelligence-based analytical method for the spectrum signal generated through the irradiation of light into the urine can identify people with prostate cancer and pancreatic cancer with an accuracy of up to 99 percent.
